Literature DB >> 25214531

The epidemiology of revision anterior cruciate ligament reconstruction in Ontario, Canada.

Timothy Leroux1, David Wasserstein2, Tim Dwyer3, Darrell J Ogilvie-Harris4, Paul H Marks2, Bernard R Bach5, John B Townley3, Nizar Mahomed6, Jaskarndip Chahal4.   

Abstract

BACKGROUND: Knowledge of the rate of and risk factors for re-revision, reoperation, and readmission after revision anterior cruciate ligament reconstruction (ACLR) is limited.
PURPOSE: To determine the rate of and risk factors for re-revision, reoperation, and readmission after revision ACLR. STUDY
DESIGN: Descriptive epidemiology study.
METHODS: All patients who underwent first revision ACLR in Ontario, Canada, from January 2004 to December 2010 were identified and followed until December 2012. Exclusions included age <16 years, previous osteotomy, or multiligament knee reconstruction. The main outcome was re-revision ACLR. Secondary outcomes included reoperation (irrigation and debridement [I&amp;D], meniscectomy, manipulation under anesthesia, contralateral ACLR, and total knee arthroplasty) and readmission. Survival to re-revision was determined using the Kaplan-Meier approach. A Cox proportional hazards model or logistic regression were used to determine the influence of patient, surgical, and provider factors on outcomes. A post hoc analysis was performed to determine the influence of the aforementioned factors on postoperative infection risk.
RESULTS: Overall, 827 patients were included (median age, 30 years; 58.8% males). Single-stage revisions comprised 92.9% of cases, and a meniscal procedure (repair or debridement) was performed in 45.3% of cases. The re-revision rate at a mean follow-up of 4.8 ± 2.2 years was 4.4%, and the 5-year survival rate was 95.4%. The rates of I&amp;D, meniscectomy, contralateral ACLR, and readmission were 0.8%, 3.1%, 3.4%, and 4.1%, respectively. Manipulation under anesthesia and total knee arthroplasty were rare. Young age significantly increased contralateral ACLR risk (risk decreased by 5.1% with each year of age >16 years; P = .02) but not re-revision ACLR risk. Low surgeon's annual volume of revision ACLR (<4 revisions/year: odds ratio, 1.2; P = .02) and male sex (odds ratio, 13.3; P = .01) significantly increased overall infection risk; male sex also influenced I&amp;D risk.
CONCLUSION: Re-revision, reoperation, and readmission rates after revision ACLR were low, and the risk for I&amp;D, infection, and contralateral ACLR were influenced by male sex, low surgeon volume, and young age, respectively. CLINICAL RELEVANCE: This is the first study to determine morbidity rates and risk factors after revision ACLR, providing reference data from the general population.
© 2014 The Author(s).

Entities:  

Keywords:  epidemiology; re-revision; readmission; reoperation; revision ACL reconstruction

Mesh:

Year:  2014        PMID: 25214531     DOI: 10.1177/0363546514548165

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  17 in total

1.  Meniscal and Articular Cartilage Predictors of Clinical Outcome After Revision Anterior Cruciate Ligament Reconstruction.

Authors: 
Journal:  Am J Sports Med       Date:  2016-05-09       Impact factor: 6.202

2.  Two-Stage Revision Anterior Cruciate Ligament Reconstruction: Bone Grafting Technique Using an Allograft Bone Matrix.

Authors:  Jorge Chahla; Chase S Dean; Tyler R Cram; David Civitarese; Luke O'Brien; Samuel G Moulton; Robert F LaPrade
Journal:  Arthrosc Tech       Date:  2016-02-22

3.  Medial meniscal and chondral pathology at the time of revision anterior cruciate ligament reconstruction results in inferior mid-term patient-reported outcomes.

Authors:  Kate E Webster; Julian A Feller; Alexander Kimp; Brian M Devitt
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-03-07       Impact factor: 4.342

Review 4.  What Is the Mid-term Failure Rate of Revision ACL Reconstruction? A Systematic Review.

Authors:  Alberto Grassi; Christopher Kim; Giulio Maria Marcheggiani Muccioli; Stefano Zaffagnini; Annunziato Amendola
Journal:  Clin Orthop Relat Res       Date:  2017-10       Impact factor: 4.176

5.  Practice Patterns for Revision Anterior Cruciate Ligament Reconstruction in an Integrated Health Care System.

Authors:  Christopher M Gibbs; Jonathan D Hughes; Philipp W Winkler; Maya Muenzer; Bryson P Lesniak; Volker Musahl
Journal:  Orthop J Sports Med       Date:  2022-07-14

Review 6.  Controversies in ACL revision surgery: Italian expert group consensus and state of the art.

Authors:  Fabrizio Matassi; Niccolò Giabbani; Enrico Arnaldi; Alessandro Tripodo; Giovanni Bonaspetti; Corrado Bait; Mario Ronga; Paolo Di Benedetto; Stefano Zaffagnini; Eugenio Jannelli; Alfredo Schiavone Panni; Massimo Berruto
Journal:  J Orthop Traumatol       Date:  2022-07-15

Review 7.  Supplementary Lateral Extra-articular Tenodesis for Residual Anterolateral Rotatory Instability in Patients Undergoing Single-Bundle Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials.

Authors:  Yunhe Mao; Kaibo Zhang; Jian Li; Weili Fu
Journal:  Orthop J Sports Med       Date:  2021-05-07

8.  Correlation of Isokinetic Testing and ACL Failure With the Short Graft Tape Suspension Technique at Six Months.

Authors:  Mathieu Severyns; Stéphane Plawecki; Guillaume-Anthony Odri; Tanguy Vendeuvre; Frédéric Depiesse; Jean-Francois Flez; Louis-Antoine Liguori
Journal:  Arthrosc Sports Med Rehabil       Date:  2022-01-06

9.  Rates of Deep Venous Thrombosis and Pulmonary Embolus After Anterior Cruciate Ligament Reconstruction: A Systematic Review.

Authors:  Brandon J Erickson; Bryan M Saltzman; Kirk A Campbell; Yale A Fillingham; Joshua D Harris; Anil K Gupta; Bernard R Bach
Journal:  Sports Health       Date:  2015-05       Impact factor: 3.843

10.  Low annual hospital volume of anterior cruciate ligament reconstruction is not associated with higher revision rates.

Authors:  R Kyle Martin; Andreas Persson; Gilbert Moatshe; Anne Marie Fenstad; Lars Engebretsen; Jon Olav Drogset; Håvard Visnes
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-07-08       Impact factor: 4.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.